Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
Condition: Dyslipidemia Associated With Type II Diabetes Mellitus Interventions: Drug: Atorvastatin 20 mg / Fenofibrate 160 mg in fixed dose; Drug: Atorvastatin (Lipitor ®) Sponsor: Laboratorios Silanes S.A. de C.V. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2021 Category: Research Source Type: clinical trials
Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial
Condition: Hyperbilirubinemia, Neonatal Intervention: Drug: Fenofibrate Capsules Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2021 Category: Research Source Type: clinical trials